# DuPont's OxyMem invests in Ireland manufacturing facility for MABR systems

DuPont's OxyMem is investing in its manufacturing facility in Ireland to develop more efficient and reliable production technology for its membrane aerated biofilm reactor (MABR) systems used in wastewater treatment, and to provide additional staff training.

- Type: Investment
- Announced: 2022-05-01
- Where: Ireland, Ireland
- Status: announced
- Products: membrane aerated biofilm reactor (MABR) systems
- Sectors: [Water Treatment Equipment](https://endata.com/sectors/water-treatment-equipment.md)

## Companies

- [DuPont](https://endata.com/companies/13205.md)

## Sources

- [doi.org](https://doi.org/10.12968/s0958-2118(22)70057-2), 2022-05-01: "DuPont's OxyMemTM, which researches, develops and manufactures advanced membrane aerated biofilm reactor (MABR) systems that treat and purify municipal and industrial wastewater, is investing in its manufacturing facility based in Ireland."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.